During the past decade, Southern Utah Kidney and Hypertension Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southern Utah Kidney and Hypertension Center" are "Anemia" (1 trials), "Chronic Kidney Disease (CKD)" (1 trials), "Focal Segmental Glomerulosclerosis" (1 trials), "Hyperkalemia" (1 trials) and "Nephrotic Syndrome" (1 trials). Many other conditions were trialed in "Southern Utah Kidney and Hypertension Center" in a lesser frequency.

Most popular intervention types in "Southern Utah Kidney and Hypertension Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "ADX-629" (1 trials), "HX575 epoetin alfa" (1 trials), "Irbesartan" (1 trials), "Placebo ( subacute phase)" (1 trials) and "Placebo (acute phase)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Utah Kidney and Hypertension Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Southern Utah Kidney and Hypertension Center". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southern Utah Kidney and Hypertension Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Utah Kidney and Hypertension Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".